CV Sciences, Inc. (OTCMKTS:CVSI) is a science-based company specializing in the development, manufacturing, and marketing of hemp-derived cannabidiol (CBD) health and wellness products. Since its founding in 2014, the company has focused on rigorous scientific research and development to ensure product safety, quality, and consistency. CV Sciences leverages in-house extraction and formulation capabilities to deliver a range of consumer goods designed to address wellness needs such as stress management, sleep support, and general health maintenance.
The company’s flagship brand, PlusCBD Oil™, offers a portfolio of products that includes softgels, tinctures, gummies, topicals, and pet supplements. By adhering to current Good Manufacturing Practices (cGMP) standards, CV Sciences ensures each batch meets stringent purity and potency benchmarks. The company conducts extensive third-party testing for cannabinoid profile, terpene content, and the absence of pesticides, heavy metals, and residual solvents. This scientific rigor underpins CV Sciences’ commitment to transparency, with lab reports readily accessible to consumers via QR codes on packaging and the company’s website.
CV Sciences markets its products through a diversified distribution network spanning the United States, Europe, Australia, and select markets in Asia. Its go-to-market strategy combines direct-to-consumer e-commerce channels, strategic retail partnerships with health and wellness retailers, and selective collaborations with licensed dispensaries. The company’s international expansion is supported by local regulatory expertise and partnerships that navigate evolving hemp and CBD legislation, enabling compliant product registrations and import approvals in key regions.
Leadership at CV Sciences is anchored by co-founder and Chief Executive Officer Michael Lewis, who brings extensive experience in consumer packaged goods and biotech product commercialization. The management team includes experts in botanical extraction, regulatory affairs, and quality assurance, ensuring that product innovation remains aligned with emerging science and consumer demand. Moving forward, CV Sciences continues to invest in clinical research and branded product innovation to strengthen its market position and support long-term growth in the global CBD wellness sector.
AI Generated. May Contain Errors.
Free CVSI Stock Alerts